CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
will be conducted to assess the safety and tolerability of ferric citrate in pediatric participants with hyperphosphatemia related to chronic kidney...
Phase 3
Birmingham, Alabama, United States and 12 other locations
to evaluate efficacy, safety and tolerability of treatment with zibotentan/dapagliflozin and dapagliflozin alone in participants with chronic kidney...
Phase 3
Irondale, Alabama, United States and 321 other locations
pharmacokinetics, and CRP-lowering effect of quarterly and monthly subcutaneous administration of TOUR006 in participants with chronic kidney...
Phase 2
Birmingham, Alabama, United States and 4 other locations
Primary Objective:Evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH).Secondary Objectives:Eva...
Phase 3
Birmingham, Alabama, United States and 29 other locations
evaluate the efficacy and safety of CIN-107 for the treatment of hypertension in patients with uncontrolled hypertension (uHTN) and Chronic Kidney...
Phase 2
Birmingham, Alabama, United States and 70 other locations
The major objective is to demonstrate the safety and efficacy of ANG-3070 in patients with primary glomerular disease and persistent protein...
Phase 2
Birmingham, Alabama, United States and 28 other locations
(for example heart attack and stroke) in people with cardiovascular disease, chronic kidney disease and inflammation.Parti...
Phase 3
Birmingham, Alabama, United States and 943 other locations
and adolescent participants with anemia associated with chronic kidney disease (CKD) incorporating 2 independent sub-trials (Non di...
Phase 3
Birmingham, Alabama, United States and 33 other locations
of serious heart-related complications or prevent the worsening of kidney function. The trial will enroll adults with body mass index 27 kg/ ...
Phase 3
Birmingham, Alabama, United States and 348 other locations
The ASSIST study is a phase 2, double-blind, placebo-controlled crossover study to evaluate the safety and efficacy of atrasentan vs. placebo in subj...
Phase 2
Birmingham, Alabama, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal